FDA Seizes Infusion Pumps Amid Safety Fears
The FDA said Monday that after getting a search warrant, it seized approximately 1,300 units of Alaris Signature Edition Gold infusion pumps. The pumps have a design defect called “key bounce” that could cause patients to receive more medicine than intended, according to the FDA.
The seizure was meant to ensure that...
To view the full article, register now.